Status:
WITHDRAWN
Oncology Research Information Exchange Network in Improving Genetic Screening Rate in Patients With Cancer
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This research trial studies how well Oncology Research Information Exchange Network (ORIEN) works in improving genetic screening rate in patients with cancer. Implementation of Progeny Genetic Pedigre...
Detailed Description
PRIMARY OBJECTIVES: I. Measure the change in uptake of cancer genetic referrals and genetic testing in the ORIEN system of cancer centers implementing the Progeny Family History Questionnaire (FHQ). ...
Eligibility Criteria
Inclusion
- Limited to those patients who are consented to the Total Cancer Care Protocol (TCCP) protocol
- Able to understand and sign the TCCP informed consent, California subject?s bill of rights, Health Insurance Portability and Accountability Act (HIPAA), and research authorization form directly or through an authorized representative; the informed consent, subject?s bill of rights, HIPAA, and research authorization will be available in both English and Spanish languages
Exclusion
- Individuals who are not registered as patients for outpatient or inpatient care to the TCCP protocol
- Individuals who are unable to understand or sign the TCCP informed consent, subject?s bill of rights, HIPAA, and research authorization in either English or Spanish
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2038
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03348137
Start Date
July 1 2019
End Date
July 1 2038
Last Update
October 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033